Harmonization in Biosimilars Webinar

October 19, 2012 9:03 AM

Biopractice is organizing a live webinar about biosimilars on 23rd of October. 

The 90 minutes webinar from Dr. Hoss A Dowlat and Christopher Ohly will cover the following areas:

  • Current information about the new EMA policy and it potential effects on the newly released EU guidances on biosimilars containing monoclonal antibodies (mAbs) and other proteins.
  • The biosimilar consultation “cluster” of the EMA and FDA will make advancement with this announcement. This opportunity will be explained
  • Examples of implications of the new policy in drug development.
  • Approaches to approval of biosimilars in the EU and US in light of the newly announced EMA policy.
  • This webinar and dialogue will focus on the far reaching importance of the new EMA policy to allow foreign reference products.
  • The regulatory and legal experts speakers will provide strategic insights into the impact of EMA announcement on biosimilars international development particularly US/EU.

If you want to attend this conference, you can find more information here.

Would you like to post an event on Biosimilar News?

Comments are closed

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!